Brainstorm Cell Therapeutics Inc. (BCLI)
R&D Expenses
-$782.00K
TTM · Period ending: · USD
BCLI R&D Expenses
Latest reported-$782.00Kperiod ending
Latest reported-$782.00Kperiod ending
BCLI R&D Expenses ($0.00 → -$782.00K)
Annual R&D Expenses
High-resolution chart · PNG
BCLI r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 4,175,000 | |
| 4,411,000 | |
| 10,481,000 | |
| 13,956,000 | |
| 15,235,000 | |
| 22,329,000 | |
| 17,204,000 | |
| 8,293,000 | |
| 977,000 | |
| 2,250,000 | |
| 4,949,000 | |
| 4,772,000 | |
| 2,917,000 | |
| 1,770,000 | |
| 1,689,000 | |
| 1,045,000 | |
| 181,000 | |
| 1,639,000 | |
| 1,925,000 | |
| 741,923 | |
| 16,350,493 | |
| 0 | |
| 0 | |
| 0 |